search
Back to results

A Dietary Supplement for Early Cigarette Withdrawal (CIGAR)

Primary Purpose

Nicotine Dependence, Cigarettes, With Withdrawal

Status
Completed
Phase
Phase 2
Locations
Canada
Study Type
Interventional
Intervention
Dietary Supplement
Lactose Placebo
Sponsored by
Centre for Addiction and Mental Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Nicotine Dependence, Cigarettes, With Withdrawal focused on measuring Cigarette, Withdrawal, Nicotine

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • males and females
  • age 18-65
  • generally good physical health
  • not using any illicit substances
  • smoke on average at least 20 cigarettes/day.

Exclusion Criteria:

  • Recent history of myocardial infarction and / or stroke
  • active substance abuse except for nicotine and active fluctuant medical conditions. (present and ongoing within 3 months)
  • Score of higher than 7 on the 17- item Hamilton Depression Rating Scale
  • Positive results for the pregnancy testing done on the first assessment visit.
  • A specific allergy to fruit-based ingredient.

Sites / Locations

  • Centre for Addiction and Mental Health

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Healthy Smokers (Active then Placebo)

Healthy Smokers (Placebo then Active)

Arm Description

Healthy individuals who smokes at least 20 cigarettes per day Interventions: Dietary Supplement, Lactose Placebo

Healthy individuals who smokes at least 20 cigarettes per day Interventions: Dietary Supplement, Lactose Placebo

Outcomes

Primary Outcome Measures

Change in the Visual Analog Scale as Compared to Baseline Compared Across Two Conditions
VAS uses a 10-cm scale for participants to indicate the extent to which each of them feel happy or sad. The change in VAS before versus after sad mood induction is the change score in VAS. The change score on the day with active dietary supplement is compared to the change score on the day with the placebo dietary supplement.

Secondary Outcome Measures

Potential Side Effects Questionnaire
Structured questionnaires to assess the potential occurrence of side effects from Component A and Component B of the DS. In general, reported Component A side effects are fairly minor. Some of the reported side effects include nausea, headaches, fatigue, heartburn and joint pain. Reported side effects with Component B include: drowsiness, nausea and headaches, dizziness, fatigue, and lethargy
Profile of Mood States
The POMS contains 65 adjectives rated by participants on a 5-point scale. Six factors are derived that include tension, depression, anger, fatigue, vigor and confusion.

Full Information

First Posted
January 16, 2014
Last Updated
February 13, 2018
Sponsor
Centre for Addiction and Mental Health
search

1. Study Identification

Unique Protocol Identification Number
NCT02042521
Brief Title
A Dietary Supplement for Early Cigarette Withdrawal
Acronym
CIGAR
Official Title
A Dietary Supplement for Early Cigarette Withdrawal
Study Type
Interventional

2. Study Status

Record Verification Date
February 2018
Overall Recruitment Status
Completed
Study Start Date
January 2014 (undefined)
Primary Completion Date
March 2016 (Actual)
Study Completion Date
March 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Centre for Addiction and Mental Health

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether a dietary supplement (DS) is effective in protecting against sad mood during early cigarette withdrawal. This study will also assess whether the dietary supplement will be well tolerated during early cigarette withdrawal.
Detailed Description
100 subjects who smoke at least 20 cigarettes per day will come in on two different days, at least one week apart, in a randomized, double blind, within subject, placebo controlled design. On each day subjects will refrain from smoking cigarettes for 8 hours. On one day subjects will take the active DS (taken in two doses, the evening dose is taken at 22:00 of the night before the test day and the morning dose is taken at 8:00 of the test day) and on the other day subjects will take placebo (also taken in two doses at the same time points of the active DS). Mood symptoms and symptoms of cigarette withdrawal will be compared across the two different days. Measures of mood symptom monitoring will include self report on a scale of 1 to 10, standardized rater questions about mood, and 6 hours into withdrawal, a standardized mood induction will be done with mood assessment. Symptoms of cigarette withdrawal will be assessed over the duration of withdrawal with applied standardized rating scales by trained raters. For the first 15 - 30 subjects, on each day, a health assessment of a physical exam and blood work will be completed at the end of the withdrawal period on both test days as well as for the initial assessment appointment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nicotine Dependence, Cigarettes, With Withdrawal
Keywords
Cigarette, Withdrawal, Nicotine

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
21 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Healthy Smokers (Active then Placebo)
Arm Type
Experimental
Arm Description
Healthy individuals who smokes at least 20 cigarettes per day Interventions: Dietary Supplement, Lactose Placebo
Arm Title
Healthy Smokers (Placebo then Active)
Arm Type
Experimental
Arm Description
Healthy individuals who smokes at least 20 cigarettes per day Interventions: Dietary Supplement, Lactose Placebo
Intervention Type
Drug
Intervention Name(s)
Dietary Supplement
Intervention Description
The active evening dietary supplement is taken at 22:00. The active morning dietary supplement is taken at 8:00-8:15. The active evening dietary supplement is taken first. The active morning and evening dietary supplements are taken within 12 hours in time points as specified above.
Intervention Type
Drug
Intervention Name(s)
Lactose Placebo
Other Intervention Name(s)
Placebo
Intervention Description
This research study involves a placebo dietary supplement that does not have any of or only partial of the active ingredients in the active dietary supplement. The placebo dietary supplement will be given in identical time points to match that of the active dietary supplements.
Primary Outcome Measure Information:
Title
Change in the Visual Analog Scale as Compared to Baseline Compared Across Two Conditions
Description
VAS uses a 10-cm scale for participants to indicate the extent to which each of them feel happy or sad. The change in VAS before versus after sad mood induction is the change score in VAS. The change score on the day with active dietary supplement is compared to the change score on the day with the placebo dietary supplement.
Time Frame
Two sessions at least one week apart
Secondary Outcome Measure Information:
Title
Potential Side Effects Questionnaire
Description
Structured questionnaires to assess the potential occurrence of side effects from Component A and Component B of the DS. In general, reported Component A side effects are fairly minor. Some of the reported side effects include nausea, headaches, fatigue, heartburn and joint pain. Reported side effects with Component B include: drowsiness, nausea and headaches, dizziness, fatigue, and lethargy
Time Frame
Twice on both test days: once in the morning right before the morning active or placebo dietary supplement and once more right after the observed break
Title
Profile of Mood States
Description
The POMS contains 65 adjectives rated by participants on a 5-point scale. Six factors are derived that include tension, depression, anger, fatigue, vigor and confusion.
Time Frame
Anytime during initial assessment visit. On both test days, at least 1 week apart at: (7:35-8:00); (8:40-9:05); (11:20-11:45); (12:25-12:50); (13:10-13:30); (14:30-14:55)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: males and females age 18-65 generally good physical health not using any illicit substances smoke on average at least 20 cigarettes/day. Exclusion Criteria: Recent history of myocardial infarction and / or stroke active substance abuse except for nicotine and active fluctuant medical conditions. (present and ongoing within 3 months) Score of higher than 7 on the 17- item Hamilton Depression Rating Scale Positive results for the pregnancy testing done on the first assessment visit. A specific allergy to fruit-based ingredient.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jeffrey H. Meyer, MD, PhD
Organizational Affiliation
Research Imaging Centre, Centre for Addiction and Mental Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre for Addiction and Mental Health
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5T 1R8
Country
Canada

12. IPD Sharing Statement

Links:
URL
http://www.camh.ca/research
Description
Information about research at the Centre for Addiction and Mental Health

Learn more about this trial

A Dietary Supplement for Early Cigarette Withdrawal

We'll reach out to this number within 24 hrs